The BATURA Study is a fully virtual clinical research study evaluating an investigational drug for people 12 years and older diagnosed with asthma and are using a rescue inhaler – with or without other medication – to control their symptoms. Who is eligible to participate in this clinical research study? You may be eligible to participate, if you: • Are 12 years of age and older* • Have had a clinical diagnosis of asthma, by a healthcare professional • Are actively using Short-acting Beta-agonist inhalers (as-needed rescue inhaler, such as albuterol) to control or reduce asthma symptoms, alone or in combination with either low dose inhaled corticosteroid (Flovent®, Pulmicort®, or Asmanex®) or leukotriene inhibitor montelukast (Singulair), zileuton (Zyflo®), or zafirlukast (Accolate®). • Meet additional study criteria.
*Parental consent is required for individuals under 18 years of age. Study staff will determine eligibility based on additional study criteria. Feel free to reach out to the Clinical Trial Coordinator, Shannon, at shannon.davis@exclusiveresearchconsultant.com if you have any questions or are interested in learning more.